Product Description for LNX1
anti LNX1.
Properties: Control Peptide
Presentation: Purified
Properties: Control Peptide
Presentation: Purified
Properties for LNX1
| Product Category | Control Peptides |
|---|---|
| Quantity | 50 µg |
| Synonyms | E3 ubiquitin-protein ligase LNX, LNX, LNX-1, Ligand of Numb-protein X 1, Numb-binding protein 1 |
| Presentation | Purified |
| Clonality | Polyclonal |
| Shipping to | Worldwide |
| PDF datasheet | View Datasheet |
| Manufacturer | OriGene Technologies GmbH |
| Material safety datasheet | MSDS for Polyclonal Antibodies (de) |
Datasheet Extract
| Immunogen |
|
|---|---|
| Add. information | Molecular Weight: 80.6 kDa kDa |
| Application | Western blot. Positive Control: Protein expressed in heart, placenta, kidney, pancreas and brain. |
| Background | LNX1 is an E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of NUMB. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Mediates ubiquitination of isoform p66 and isoform p72 of NUMB, but not that of isoform p71 or isoform p65. |
| Concentration | Lot specific |
| General Readings |
|
| Storage | Store at -20°C. Avoid repeated freezing and thawing. Shelf life: one year from despatch. |
| Format |
|
| Specificity |
|
| Gene ID | 84708 |
Accessory Products
Recommended Secondary Antibodies for LNX1 (0 products)
Compare Products
You have no items to compare.
My Cart
You have no items in your shopping cart.
